The coconut oil is known for its antimicrobial and soothing properties, largely attributed to its high content of medium-chain fatty acids, particularly lauric acid. In the virgin coconut oil, this fatty acid can comprise approximately 45 to 52% of the lipid composition. Lauric acid can be converted by certain enzymes, lipases, into several derivatives, including monolaurin, compounds possessing both hydrophilic and lipophilic properties and recognised for their antimicrobial activity.
Several experimental studies have shown that lauric acid and monolaurin exhibit a broad-spectrum antibacterial, antifungal and antiviral activity. In particular, they can disrupt the membrane integrity of certain microorganisms, contributing to the inactivation of Gram-positive bacteria such as Staphylococcus aureus, yeasts such as Candida albicans, as well as lipid-enveloped viruses, including herpes simplex virus (HSV) and vesicular stomatitis virus (VSV). This ability to perturb membrane structures is one of the main antimicrobial mechanisms of coconut oil.
It is in this context that the hypothesis that coconut oil may affect warts emerged. For reference, warts are caused by the human papillomavirus (HPV), a cutaneous virus. However, unlike lipid-enveloped viruses sensitive to monolaurin, HPV lacks a lipid envelope, which theoretically limits the antiviral scope of coconut oil. Moreover, in the absence of available data on the potential antiviral effects of coconut oil against HPV, it is difficult to assess its efficacy against warts.
Thus, while the biochemical composition of coconut oil suggests potential antimicrobial properties, its usefulness in managing warts must be confirmed in clinical trials.